What is Hutchinson-Gilford Progeria Syndrome?

Hutchinson-Gilford progeria syndrome (HGPS) is an exceptionally rare, fatal genetic condition characterized by premature aging in children.Individuals with HGPS typically appear normal ⁣at birth but begin to exhibit signs of accelerated aging within the ⁤first two years of life. These signs include growth retardation, hair loss, and cardiovascular problems. The‍ average ⁢lifespan for children with ⁤HGPS is around 14 years, though some may live longer.

New Research Reveals microrna Role in adipogenesis

A new study, published on August 27, 2025, in Aging-US, sheds light on the metabolic ‍complications experienced by children with HGPS. Researchers, led by Felix quirin Fenzl and corresponding author Karima Djabali at the Technical University of Munich (TUM), discovered that two microRNAs – miR-145-5p and miR-27b-3p – are deregulated in HGPS and interfere with the growth of fat cells (adipogenesis). doi.org/10.18632/aging.206309

This finding is significant because patients with HGPS often experience significant fat ⁢loss and related metabolic issues. The study‍ suggests that the deregulation of these microRNAs contributes to this fat loss, possibly exacerbating the disease’s progression.

Understanding MicroRNAs and Adipogenesis

micrornas (miRNAs) are small non-coding RNA molecules that play a crucial role in regulating gene expression. They bind to messenger RNA (mRNA) molecules,preventing them from being translated into proteins. This regulatory function impacts a wide range of biological processes, including cell development, differentiation, and metabolism.

Adipogenesis is the process by which fibroblasts differentiate into adipocytes (fat cells). This process is essential for energy storage, hormone⁣ regulation, and overall metabolic health.Disruptions in ⁢adipogenesis can lead to metabolic ‍disorders,including obesity and lipodystrophy (loss of fat ⁢tissue).

study Findings:⁤ miR-145 and miR-27b in HGPS

The researchers found that miR-145-5p and miR-27b-3p are abnormally expressed in cells from children with HGPS. Specifically, these microRNAs appear to ‍inhibit the expression of genes ⁢crucial for adipogenesis. This inhibition⁢ leads to reduced fat cell formation and contributes to the observed fat loss in HGPS patients.

Further investigation revealed that⁤ these microRNAs target specific pathways involved in adipocyte differentiation, effectively blocking the process. This provides a mechanistic explanation for ⁢the ⁣metabolic phenotype observed in HGPS.

Implications for treatment and Future Research

The identification of miR-145 and miR-